Abstract:Injectable hydrogels, as an effective vehicle for localized drug delivery, have attracted increasing attention in recent years. With improved tumor-specific drug accumulation and lowered risk of infection, the application of in situ-forming injectable hydrogels provides an alternative to surgical implantation. In this study, based on a unique feature of regenerated silk fibroin (RSF) that it can easily form beta-sheet structures, which function as physical cross-links, under various conditions, we designed an injectable silk fibroin hydrogel which encapsulated SBA-15 for the co-delivery of a vascular disrupting agent, combretastatin A4 disodium phosphate (CA4P), and doxorubicin hydrochloride (DOX). Such a CA4P and DOX co-encapsulated hydrogel ((RSF/CA4P)-(SBA-15/DOX)), simply prepared through a designed ultrasonication procedure, showed two different types of drug release behavior. CA4P was rapidly released, and it not only targeted the abnormal vasculature of tumors, causing vascular collapse, but also inhibited tumor cell proliferation by binding to tubulin and arresting mitosis. On the other hand, the sustained release of DOX can inhibit the proliferation of tumor cells for a prolonged period of time. Because of the rapid disruption of tumor vasculature and sustained inhibition of tumor cells proliferation, the (RSF/CA4P)-(SBA-15/DOX) hydrogel showed significantly enhanced cytotoxicity against human breast carcinoma cells (MDA-MB-231). By using this co-delivery system, the required dose of DOX can be lowered, and at the same time, the superior antitumor efficacy of the drugs is maintained. Our results suggest that the application of silk fibroin hydrogels to the co-delivery of a vascular disrupting agent and a chemotherapeutic agent with different drug release behaviors is a promising strategy in tumor treatment. Moreover, after sonication, the hydrogel precursor of (RSF/CA4P)-(SBA-15/DOX), can reach target irregular-shaped tumor sites via intratumor injection, and the hydrogels then form in situ, simply induced by body heat. Such silk fibroin-based hydrogels are injectable and malleable and fluorescent in dark field, which greatly facilitates their biomedical applications.

Fabrication of an Injectable Star-polylactide/Thiolated Hyaluronate Hydrogel as a Double Drug-Delivery System for Cancer Treatment

Development of a Dual Drug-Loaded Hydrogel Delivery System for Enhanced Cancer Therapy: in Situ Formation, Degradation and Synergistic Antitumor Efficiency

Development of a Dual-drug-loaded Silk Fibroin Hydrogel and Study on Its Drugs Release Behaviors

Temperature- and pH-responsive injectable chitosan hydrogels loaded with doxorubicin and curcumin as long-lasting release platforms for the treatment of solid tumors

In situ forming an injectable hyaluronic acid hydrogel for drug delivery and synergistic tumor therapy

Dual-loaded, long-term sustained drug releasing and thixotropic hydrogel for localized chemotherapy of cancer.

Injectable hyaluronic acid–cyclodextrin-based hydrogels for localized and sustained release of anticancer drugs

Injectable Halloysite-G-chitosan Hydrogels As Drug Carriers to Inhibit Breast Cancer Recurrence

An injectable hydrogel based on Bi2Se3 nanosheets and hyaluronic acid for chemo-photothermal synergistic therapy

Injectable Hydrogel-Microsphere Construct with Sequential Degradation for Locally Synergistic Chemotherapy

Fabrication of a Multi-Level Drug Release Platform with Liposomes, Chitooligosaccharides, Phospholipids and Injectable Chitosan Hydrogel to Enhance Anti-Tumor Effectiveness

Injectable and In Situ-Formable Thiolated Chitosan-Coated Liposomal Hydrogels as Curcumin Carriers for Prevention of In Vivo Breast Cancer Recurrence

Fabrication of injectable hydrogels from an anticancer peptide for local therapeutic delivery and synergistic photothermal-chemotherapy

Localized multidrug co-delivery by injectable self-crosslinking hydrogel for synergistic combinational chemotherapy

Dual Drug-Loaded PLGA Fibrous Scaffolds for Effective Treatment of Breast Cancer in Situ

Light-Induced Hydrogel Based on Tumor-Targeting Mesoporous Silica Nanoparticles As a Theranostic Platform for Sustained Cancer Treatment

Dual-Responsive Alginate Hydrogel Constructed by Sulfhdryl Dendrimer as an Intelligent System for Drug Delivery

Injectable, Thixotropic, and Multi-Responsive Silk Fibroin Hydrogel for Localized and Synergistic Tumor Therapy

Polyamidoamine dendrimer-mediated hydrogel for solubility enhancement and anti-cancer drug delivery

Preparation of Curcumin Loaded Hyaluronic Acid-Poly (Lactic-Co-glycolic Acid) Micelles with Ph Response and Tumor Targeting

Supramolecular hydrogel for programmable delivery of therapeutics to cancer multidrug resistance